Ocular Therapeutix reported a phase 3 win that it believes can validate its attempts to challenge Regeneron’s entrenched ...

DFE Pharma has launched its Continuous Manufacturing (CM) platform, designed to support pharmaceutical companies in ...

The pharmaceutical manufacturing market is poised for growth by leveraging advanced technologies, digital platforms, and robust supply chain strategies. Opportunities arise in adopting ...

In a significant step forward for mucosal immunity, Aptar Pharma has announced that its innovative nasal delivery systems are ...

The pharmaceutical sector continues to witness earnings-driven momentum as companies report resilient Q3 FY26 performance, supported by strong domestic demand, export traction, and improved ...

Natco Pharma's Q3 consolidated net profit rose 14.3% YoY to ₹152 crore, while revenue increased by 36.3%, driven by higher export formulations and other operating income.

Opinion: Freedom-to-operate analysis must be understood as a continuous, integrated process that evolves alongside science, regulation, and commercial strategy.

New sublingual delivery system designed to enhance bioavailability and speed of onset for major depressive and ...

According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...

The Fine and Specialty Chemicals Market is entering a transformative phase of high-value innovation and application-specific customization, underpinned by specialty chemicals’ critical role as ...

Márcio Temtem, Hovione, discusses how his company integrates modular hardware and modeling software to accelerate pharmaceutical R&D and optimize manufacturing processes.

Wanbury delivers strong Q3 FY26 performance with significant profit growth: Our Bureau, Mumbai Tuesday, February 10, 2026, 17:15 Hrs [IST] Wanbury Ltd, a pharmaceutical company wi ...